phenylalanine has been researched along with Heart Failure in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, K; Cao, W; Cheng, LL; Lin, Y; Shen, YH; Tao, H; Xiang, J; Xu, W; Yang, JJ; Yuan, YY; Zang, WD; Zhao, JY; Zhao, R; Zhao, SM; Zhou, Q | 1 |
| Cheng, CW; Cheng, ML; Liu, MH; Tang, HY; Wang, CH | 1 |
| Aoki, S; Awaji, Y; Hiraiwa, H; Ishihara, T; Iwata, E; Kanzaki, Y; Kato, T; Kazama, S; Kimura, Y; Kondo, S; Kondo, T; Murohara, T; Okumura, T; Sano, H; Shimojo, M; Tanimura, D; Yamada, S | 1 |
| Ala-Korpela, M; Boachie, C; Delles, C; Ford, I; Havulinna, AS; Jukema, JW; Kangas, A; McConnachie, A; Mooijaart, SP; Rankin, NJ; Salomaa, V; Sattar, N; Soininen, P; Trompet, S; Welsh, P; Würtz, P; Zannad, F | 1 |
| Cheng, ML; Liu, MH; Wang, CH | 1 |
| Cheng, ML; Fu, TC; Liu, MH; Wang, CH | 1 |
| Backman, SB; Bui, H; Hatzakorzian, R; Schricker, T | 1 |
| Cha, YM; Dzeja, PD; Nemutlu, E; Terzic, A; Xu, YZ; Zhang, S; Zhong, L | 1 |
| Ades, PA; LeWinter, MM; Matthews, DE; Toth, MJ | 1 |
| Califf, RM; Giles, T; Haffner, SM; Hernandez, AF; Krum, H; Leiter, LA; Martinez, FA; Mazzone, T; McMurray, JJ; Rutten, GE; Standl, E; Sun, JL; Thomas, L; Tognoni, G; Wong, YW | 1 |
| Barbier, S; Henry, JP; Jeng, AY; Monteil, C; Mulder, P; Renet, S; Thuillez, C | 1 |
| Emoto, N | 1 |
| Gilles, FH; Koch, R; Verma, S | 1 |
| Horio, T; Kangawa, K; Matsuo, H; Matsuoka, H; Miyata, A; Nagaya, N; Nishikimi, T; Takishita, S; Yoshihara, F; Yutani, C | 1 |
| Ergul, A; Grubbs, AL; Spinale, FG; Zhang, Y | 1 |
| Feldman, AM; Li, YY | 1 |
| Feldman, AM; Kadokami, T; Li, YY; McTiernan, CF; Wang, P | 1 |
| Lee, LM | 1 |
2 review(s) available for phenylalanine and Heart Failure
| Article | Year |
|---|---|
[Physiological and pathophysiological roles of the endothelin converting enzymes].
Topics: Animals; Aspartic Acid Endopeptidases; Benzazepines; Benzofurans; Drug Design; Endothelin-Converting Enzymes; Glycopeptides; Heart Failure; Humans; Hypertension; Metalloendopeptidases; Mice; Mice, Knockout; Myocardial Infarction; Organophosphonates; Phenylalanine; Tetracyclines; Tetrazoles | 2004 |
Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.
Topics: Animals; Enzyme Inhibitors; Extracellular Matrix; Heart Failure; Humans; Inhibitory Concentration 50; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Myocardium; Phenylalanine; Thiophenes | 2001 |
2 trial(s) available for phenylalanine and Heart Failure
| Article | Year |
|---|---|
Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997.
Topics: Aged; Biomarkers; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Incidence; Ireland; Magnetic Resonance Spectroscopy; Male; Metabolomics; Netherlands; Phenylalanine; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Scotland; Time Factors | 2018 |
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.
Topics: Adiposity; Aged; Albuminuria; Biomarkers; Blood Glucose; Creatinine; Cyclohexanes; Double-Blind Method; Female; Glucose Metabolism Disorders; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Incidence; Linear Models; Male; Middle Aged; Multivariate Analysis; Nateglinide; Nonlinear Dynamics; Obesity, Abdominal; Phenylalanine; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Waist Circumference | 2013 |
14 other study(ies) available for phenylalanine and Heart Failure
| Article | Year |
|---|---|
Nuclear ATR lysine-tyrosylation protects against heart failure by activating DNA damage response.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; DNA Damage; Heart Failure; Lysine; Mice; Phenylalanine; Tyrosine; Tyrosine-tRNA Ligase | 2023 |
Factors associated with elevated plasma phenylalanine in patients with heart failure.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Phenylalanine; Plasma; Young Adult | 2021 |
Prognostic value of leucine/phenylalanine ratio as an amino acid profile of heart failure.
Topics: Aged; Aged, 80 and over; Amino Acids, Branched-Chain; Biomarkers; Female; Follow-Up Studies; Heart Failure; Humans; Leucine; Male; Middle Aged; Phenylalanine; Prognosis; Retrospective Studies; ROC Curve | 2021 |
Amino Acid-Based Metabolic Panel Provides Robust Prognostic Value Additive to B-Natriuretic Peptide and Traditional Risk Factors in Heart Failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Biomarkers; Female; Heart Failure; Histidine; Humans; Male; Middle Aged; Ornithine; Phenylalanine; Predictive Value of Tests | 2018 |
Amino Acid-Based Metabolic Profile Provides Functional Assessment and Prognostic Value for Heart Failure Outpatients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Exercise Test; Female; Heart Failure; Histidine; Humans; Male; Metabolome; Middle Aged; Ornithine; Outpatients; Phenylalanine | 2019 |
Broken heart syndrome triggered by an obstructive goiter not associated with thyrotoxicosis.
Topics: Aged; Airway Obstruction; Echocardiography; Female; Goiter, Nodular; Goiter, Substernal; Heart Failure; Humans; Intra-Aortic Balloon Pumping; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Phenylalanine; Respiratory Insufficiency; Takotsubo Cardiomyopathy; Tracheal Stenosis; Valine | 2013 |
Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure.
Topics: Aged; Cardiac Resynchronization Therapy; Catheter Ablation; Energy Metabolism; Female; Gas Chromatography-Mass Spectrometry; Glucose; Heart Failure; Humans; Isoleucine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Myocardium; Phenylalanine; Predictive Value of Tests; Prognosis; Prospective Studies; Tachycardia, Supraventricular; Ventricular Dysfunction, Left; Ventricular Remodeling | 2015 |
Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation.
Topics: Aged; Amino Acids; Anthropometry; Biomarkers; Fasting; Heart Failure; Humans; Insulin; Insulin Resistance; Interleukin-6; Male; Middle Aged; Muscle Proteins; Muscle, Skeletal; Phenylalanine | 2010 |
Sustained improvement of cardiac function and prevention of cardiac remodeling after long-term dual ECE-NEP inhibition in rats with congestive heart failure.
Topics: Animals; Aspartic Acid Endopeptidases; Blood Pressure; Cardiac Output; Endothelin-Converting Enzymes; Heart Failure; Heart Rate; Male; Metalloendopeptidases; Neprilysin; Organophosphonates; Phenylalanine; Rats; Rats, Wistar; Tetrazoles; Ventricular Remodeling | 2004 |
Neuropathology of a 4-month-old infant born to a woman with phenylketonuria.
Topics: Adult; Agenesis of Corpus Callosum; Biopsy; Cerebrosides; Fatal Outcome; Female; Heart Failure; Humans; Infant; Magnetic Resonance Imaging; Phenylalanine; Phenylketonuria, Maternal; Pregnancy; Prosencephalon; Sulfoglycosphingolipids | 2008 |
Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart.
Topics: Animals; Atrial Natriuretic Factor; Carbon Radioisotopes; Cells, Cultured; Corticotropin-Releasing Hormone; Cyclic AMP; Gene Expression; Heart Failure; Hormone Antagonists; Hypertrophy, Left Ventricular; Immunohistochemistry; Muscle Fibers, Skeletal; Myocardium; Peptide Fragments; Phenylalanine; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Thymidine; Tritium; Urocortins | 2000 |
Selective upregulation of endothelin converting enzyme-1a in the human failing heart.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspartic Acid Endopeptidases; Cardiomyopathy, Dilated; Case-Control Studies; Endothelin-Converting Enzymes; Gene Expression Regulation; Heart Failure; Heart Transplantation; Heart Ventricles; Humans; Metalloendopeptidases; Phenylalanine; Reverse Transcriptase Polymerase Chain Reaction; Tetracyclines; Thiophenes; Up-Regulation | 2000 |
MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure.
Topics: Animals; Collagen; Enzyme Inhibitors; Heart Failure; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Transgenic; Myocardium; Phenotype; Phenylalanine; Reference Values; Survival; Thiophenes; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2002 |
An unusual alkaline phosphatase isoenzyme in a patient with concomitant marked elevation of acid phosphatase without clinical evidence of prostatic carcinoma.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Heart Failure; Homoarginine; Humans; Isoenzymes; Liver; Male; Phenylalanine; Prostatic Hyperplasia | 1976 |